The normalized expressions of NCBP3, METTL3 and eIF4A2 were evaluated in human monocytes (GSE162834), human umbilical vein endothelial cells primary human aortic endothelial cells and smooth muscle cells (GSE154427), breast cancer (GSE167956), human cardiomyocytes (GSE144424), mouse brain cortices (GSE173544), mouse heart tissues (GSE169214) and mouse hepatocytes (GSE159320). This evidence concerns the gene METTL3 and breast cancer.